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In neural prosthetics and stereotactic neurosurgery, intracortical electrodes
are often utilized for delivering therapeutic electrical pulses, and recording
neural electrophysiological signals. Unfortunately, neuroinflammation impairs the
neuron-electrode-interface by developing a compact glial encapsulation around the
implants in long term. At present, analyzing this immune reaction is only feasible with
post-mortem histology; currently no means for specific in vivo monitoring exist and most
applicable imaging modalities can not provide information in deep brain regions. Optical
coherence tomography (OCT) is a well established imaging modality for in vivo studies,
providing cellular resolution and up to 1.2mm imaging depth in brain tissue. A fiber based
spectral domain OCT was shown to be capable of minimally invasive brain imaging. In
the present study, we propose to use a fiber based spectral domain OCT to monitor the
progression of the tissue’s immune response through scar encapsulation progress in a
rat animal model. A fine fiber catheter was implanted in rat brain together with a flexible
polyimide microelectrode in sight both of which acts as a foreign body and induces the
brain tissue immune reaction. OCT signals were collected from animals up to 12 weeks
after implantation and thus gliotic scarring in vivo monitored for that time. Preliminary
data showed a significant enhancement of the OCT backscattering signal during the first
3 weeks after implantation, and increased attenuation factor of the sampled tissue due to
the glial scar formation.
Keywords: chronic implants, flexible microelectrodes, foreign body reaction, optical coherence tomography, fiber
catheter
1. INTRODUCTION
Intracortical electrodes are often employed in neuroprosthetic
applications or in clinical stereotactic surgery, to deliver therapeu-
tic electrical pulses and collect neuronal electrophysiological sig-
nals (Tronnier and Fogel, 2000; Stieglitz et al., 2009; Raspopovic
et al., 2014). A reliable and dependable electrode-tissue-interface
is crucial in this concept since a neuroprosthetic device is sup-
posed to serve functionally over long period in subject’s brain.
Unfortunately, the lifetime of a such device is always compro-
mised due to electrode corrosion or so called glial scarring around
the indwelling electrode (Edell et al., 1992; Schmidt et al., 1993;
Turner et al., 1999; Leach et al., 2010).
When an electrode is implanted into the brain, during the
acute phase of the immune reaction, microphages settle in on
the area and resident microglia cells of the immune system
become activated and start proliferating. Then astrocytes are
activated to scavenge the leftover large intruders. Unfortunately,
any type of the artificial implant is resistant to this bio degra-
dation, which induces a so called frustrated phagocytosis and
leads in consequence to a dense glial scar attempting to isolate
the implant from the delicate brain tissue (Turner et al., 1999;
Biran et al., 2005; Polikov et al., 2005; Winslow et al., 2010;
Potter et al., 2012). This isolation performed by glial sheath-
ing not only changes the electrical coupling to the surrounding
parenchyma, but may even cause neuronal loss by neurotoxic
factors released from glial cells (Block et al., 2007). This leads
to a deterioration and loss of electrophysiological signal over
time. Electrical characterization of electrode-tissue state over time
is attempted by temporally resolved impedance spectroscopy or
signal-to-noise ratio analysis (Ludwig et al., 2006; Mcconnell
et al., 2009). Immunohistochemical analysis is performed to char-
acterize astrocytes and microglial cells progression over time.
However, this requires tissue to be removed for postmortem
examination disqualifying for long term in vivo process moni-
toring of the same animal (Szarowski et al., 2003). Lately, Kozai
et al. (2012) reported using two-photon microscopy to reveal
immediate microglial reaction to electrode insertion in vivo.
However, this technique is limited to imaging only a shallow part
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(∼200µm) of the brain and only in short term (up to 7 h post
implantation).
Alternatively, clinically approved Optical Coherence
Tomography, displaying the intrinsic optical scattering properties
of the tissue, might be used instead (Huang et al., 1991; Hee et al.,
1996; Bonin et al., 2010). OCT features a spatial resolution in
cellular range of 5–10µm, up to 1.2mm imaging depth in brain
tissue, and up to 40,000 axial scans (A-scan) per second (Drexler
et al., 2001; Rodriguez-Padilla et al., 2007). When integrated with
ultra-small single mode fiber catheter, it is competent to visualize
deep brain structures with minimum trauma (Tearney et al.,
1997; Böhringer et al., 2006; Xie et al., 2013).
In the present study, we propose to use a fiber based spectral
domain OCT to monitor the progression of the tissue’s immune
response through scar encapsulation progress in a rat animal
model. We developed an integrated OCT detection probe consist-
ing of an implantable ferrule based fiber catheter and a fiber patch
cable. The fiber catheter was implanted in rat brain together with
a flexible polyimide microelectrode array in sight, according to
the procedure described in Richter et al. (2013), both intended to
induce the brain tissue immune reaction. The OCT backscatter-
ing intensity of the brain tissue around the fiber increased during
the first 3 weeks. The tissue optical attenuation coefficient altered
after implantation and reached a maximum at the week 6 imply-
ing that a compact dense tissue sheath has developed around
the fiber tip. Further more, the 10µm thick flexible probe which
located up to 2.7mm away from the fiber catheter tip is still visible
in the OCT image and A-scan plot.
2. MATERIALS AND METHODS
2.1. OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM
The imaging modality we used to monitor and assess the
foreign body reaction is fiber based spectral domain optical
coherence tomography (SDOCT) (Fercher et al., 1995). In this
imaging modality, the incident light is transmitted into tis-
sue through an implantable fiber catheter and the backscat-
tered light from the illuminated tissue is also collected by the
fiber catheter. The incident light and the backscattered light
produce an interference pattern encoding the intrinsic optical
properties of the sampled tissue. The interference pattern is
detected at a spectrometer to construct A-scan (depth-scan) sig-
nals providing the backscattered light intensity as a function of
depth.
The imaging system employed composes a commercially
available fiber-based OCT module (“Callisto,” Thorlabs GmbH,
Lübeck, Germany) utilizing a superluminescent diode (SLD) with
center wavelength at 840 nm as the light source and a single mode
fiber based sampling probe providing the feasibility of minimum-
invasive imaging (see Figure 1). When equipped with a single
mode fiber based detecting catheter, the whole system features an
axial resolution of 14µm and transversal resolution of 20µm in
air. The system’s look-ahead capability is 3.5mm from the tip of
the fiber catheter to the tissue, enabling us to evaluate the develop-
ment of the tissue reaction to the indwelling fiber catheter and to
the flexible microelectrode underneath. It has been demonstrated
that the fiber based OCT system is competent for imaging brain
anatomical structures in vivo (Xie et al., 2013).
FIGURE 1 | A schematic diagram of the Spectral Domain Optical
Coherence Tomography imaging system.
2.2. OPTICAL FIBER DETECTION CATHETER
The aim of this study is to use a chronically implanted OCT
fiber cannula to monitor and to assess brain tissue’s foreign
body reaction to it and to the also chronically implanted flexible
microelectrode. The fiber cannula chosen consists of a ceramic
FC ferrule (CF126-10, Thorlabs) with 2.5mm outer diameter
and 10.5mm total length, and a 8mm long single mode fiber
(125µm, SMF800-5.6-125, Thorlabs) in order to reach deep
brain structures (see Figure 2B bottom for geometry).
2.3. POLYIMIDE BASED FLEXIBLE MICROELECTRODE
The flexible polyimide microelectrode, which also provokes
immune response and which was implanted into the rat brain,
is designed and fabricated in-house. The probe shank is 15mm
long, 10µm thick and 365µm wide, with a smooth surface. The
substrate material of the photolithographically structured probe
is a medical grade polyimide type PI2611 (U-Varnish S, UBE,
Newyork), with a bulk YoungÕs modulus of around 10GPa over
20 months in 37◦C PBS (Rubehn and Stieglitz, 2010) (Figure 2B
left). It is exemplifying a “device under test” based on findings
(Sohal et al., 2014) that indwelling flexible substrates provoke
a less pronounced gliosis compared with rigid micro electrodes
presumably due to compliance-matching with brain tissue.
2.4. ANIMAL SURGERY AND DEVICE IMPLANTATION
All animal experiments conducted in this study were performed
with approval from the locally responsible Animal Welfare
Committe with the Regierungspräsidium Freiburg in accordance
with the guidelines of the European Union Directive 2010/63/UE.
The animal model chosen consists of adult female Sprague
Dawley rats (Charles River, Germany), weighing 280–320 g. The
rats were initially anesthetized by administering intraperitoneally
a mixture of 100mg/kg ketamine and 5mg/kg xylazine. Rats were
placed on a the heating pad of a circulating water bath set to 40◦C
to maintain a body temperature of 35◦C. The rat was then fixed
into the stereotactic frame with a pair of ear pins and a bite bar.
A 15mm long scalp incision was cut along the midline, the skin
was pulled aside to expose the skull surface structure. Bregma was
identified and served as coordinate 0.0mm. A burr hole (0.9mm
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FIGURE 2 | (A) A brief sketch of the implantations including a pair
of indwelling probe: the OCT fiber catheter and the flexible
polyimide microelectrode. (B) The picture on top-left shows the
cemented fiber optics connector and PCB for electrophysiology
recording taken on the second week after implantation surgery.
Pictures on bottom-left and right demonstrate the geometry of the
OCT fiber catheter and the flexible microelectrode connected to a
PCB, respectively.
in diameter) in the skull at 4.0mm posterior 2.0mm lateral from
Bregma was drilled. Prior to probe insertion, a small incision was
cut on the dura and pia mater underneath the burr hole with a
27G needle to avoid brain dimpling upon probe penetration.
The flexible microelectrode was inserted in the brain tissue
with the OCT fiber catheter, following the protocol prosposed
by Richter et al. (2013). The flexible microelectrode was placed
on the moist skull surface, with the shank precisely adjusted to
overlay the burr hole at the position of 4mm from the shank
distal end. The OCT fiber catheter was firmly clamped to the
micro drive equipped stereotaxic frame and positioned on top
of the burr hole. The microelectrode shank was placed between
the exposed skull and the OCT fiber precisely aligned above the
hole (Figure 3A). Slowly driving the stereotactic z arm to insert
the fiber catheter, the flexible microelectrode was pushed into the
brain by the fiber catheter (Figures 3B,C). We stopped the inser-
tion when the fiber catheter was at 6mm under the brain surface
(thalamic nucleus area) (Figure 3D). In order to avoid electrode
displacement while applying dental cement, a small drop of Super
Glue (Loctite 4061, Henkel Loctite GmbH) was applied to adhere
the rest of the electrode shank to the skull. A small amount of
bone wax was plastered to close the skull burr hole. We sealed
and tethered the connector part of the fiber catheter and the
microelectrode with adequate dental cement (Figure 2A). The
skin incision was sutured to close and wiped with betaisodona
(7.5%, B. Braun Melsungen) to prevent skin infection. Carprofen
(4mg/kg) was then administered subcutaneously for pain man-
agement each day for 5 days after surgery. The animals were
housed with daily inspection.
2.5. POST SURGERY MEASUREMENT AND OCT SIGNAL ANALYSIS
The OCT signal was collected at week 1, 2, 3, 6, and 12 after the
implantation surgery in freely moving rats. During each mea-
surement, the implanted OCT fiber catheter was connected to
the OCT sampling cable through FC/FC mating sleeve. Since
the FC ferrule features a flat endface, the presence of air at the
junction point induces significant signal loss due to the refractive
index mismatching between air and fiber material. To achieve the
maximum light transmission between the fiber catheter and the
sampling cable, we applied a thin layer (∼100µm thick) of index
matching gel (G608N3, Thorlabs) at the junction part. Signal
acquisition was performed for about 5min in each measurement
section for analysis.
The OCT signal is presented in gray scale images each of which
consists of 1000 A-scan signals aligned in x-axis (see Figure 4
left panels). Depth-scan profile is plotted by taking an average
of 1000 A-scans (see Figure 4 right panels). For quantification
of OCT signals, we calculated the light attenuation factor of the
sampled tissue by analysing A-scan signals. The light attenuation
factor was defined as the ratio of detected light intensity decline
in depth (mm). It is proportional but not equal to the tissue
attenuation coefficient which is one of the essential tissue optical
properties reflecting the tissue composition and density. A change
in attenuation factor implies alterations in tissue properties, such
as cell density, cell orientation, predominate cell type and hence
backscatter ability. Attenuation factor is calculated as the slope
value of the linear fit for the log intensity of the linear portion
depth in an A-scan plot (see the red lines on plots in Figure 4).
2.6. HISTOLOGY AND IMMUNOSTAINING
Rats were terminated by administering Ketamine and Xylazine
mixture intraperitonealy. The brains were removed immediately
after decapitation, fixed in 4% paraformaldehyde (PFA) in PBS
for 4 days, and then incubated in 30% sucrose in PBS for at least
2 days. During the brain removal procedure, the flexible micro-
electrode and the OCT fiber probe were carefully cut from their
skull-tethered part and were PFA fixed within the brain. Prior to
sectioning, the OCT fiber probe was explanted from the brain
while the flexible microelectrode was kept in situ in the brain.
Brains were then embedded in Tissue-Tek O.C.T. (Sakura Finetek,
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FIGURE 3 | Probe implantation procedures. The flexible microelectrode and fiber catheter are precisely aligned above the burr hole (A). The fiber catheter is
slowly and cautiously driven down to push the shank of the flexible mciroelectrode into the brain (B,C) until the desired depth is reached (D).
Germany) at −20◦C. 20µm thick transversal or coronal slices
were obtained with a cryostat-microtome at −20◦C.
Brain slices were double-immunostained for GFAP (glial
fibrillary acidic protein) to detect astrocytes and Iba1 (ion-
ized calcium-binding adapter molecule (1) to identify
microglia/macrophages. Brain slices were incubated in 10%
goat serum to block non-specific binding, then incubated in
GFAP antibody (1:1000 dilution, rabbit IgG, Millipore) and Iba1
antibody (1:500 dilution, Goat IgG, Abcam) for 3 h. After 3 rinses
in PBS (5min each), fluorescence-labeled secondary antibodies
AlexaFluro 488 anti-rabbit and AlexaFluro 647 anti-goat were
applied for 1 h. Both secondary antibodies (Molecular Probes)
were used in 1: 1000 dilution. After 3 rinses in PBS (5min
each), brain slices were mounted onto the microscopic slides
with Dapi-Fluoromount-G (Southern Biotech) and then covered
with a coverslip. Slice images were collected with Jenoptik
camera mounted on a Zeiss microscope (Zeiss Imager a1),
using the identical exposure time for each immunolabel at each
magnification.
3. RESULTS
3.1. OCT SIGNALS FROM THE TISSUE AROUND THE INDWELLING
FIBER CATHETER
During 6 weeks after the implantation, the intensity of the OCT
signal increased from 60 to 70 dB (Figures 4A–C). Fromweek 6 to
week 12, the OCT signal intensity didn’t demonstrate noticeable
change (Figures 4C,D). Some sparsely distributed microscopic
structures could be identified close to the fiber catheter 1 week
post operation, having the shape of as several horizontal stripe
patterns and appear in the A-scan signal as multiple peaks
(Figure 4A). At week 6, a 200µm thick layer of tissue with high
backscattering signal had developed around the fiber catheter
(Figure 4C). This high reflecting tissue layer developed into a
prominent feature in the OCT image at week 12, with a smooth A-
scan plot profile (Figure 4D). At week 6 and 12, the OCT signal
attenuated faster featuring a steep declining slope in the A-scan
plot while the backscattering intensity from the tissue surround-
ing the fiber probe stayed steady at 70 dB (see Figures 4C,D).
To further characterize the OCT signal, the attenuation factor of
4 animals on each measurement were calculated and presented
in Figure 5. In general, the attenuation factor evidently raised
during the first 3 weeks after the implantation, implying that a
compact dense tissue layer was developing during this period.
Then the attenuation factor stabilized at 6 weeks and 12 weeks
post implantation.
3.2. OCT SIGNALS OF THE INDWELLING FLEXIBLE MICROELECTRODE
At week 1 post implantation, the signal from the flexible probe
was evidently visible in the A-scan signal located at 2.3mmunder-
neath the OCT fiber catheter tip. The maximum backscattering
intensity of the OCT signal at week 1 post implantation (p.i.) is
about 59 dB, while the backscattering intensity from the flexible
electrode is approximately 35 dB presenting a a clearly visible peak
(Figure 6A). Since before it reached the flexible probe the incident
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FIGURE 4 | OCT images and the corresponding A-scan profiles
acquired at week 1, 3, 6, and 12 after implantation. The
intensity of the backscattered light increased during the first 3
weeks post implantation (A,B), while at week 6 and 12 the OCT
signal attenuated faster featuring a steep declining slope in the
A-scan plot (C,D). Arrows in panel (A) indicate the anatomic micro
structures viewed by the OCT. Arrows in panel (C) indicate a
200µm thick layer is expressed in the OCT signal.
light was presumably scattered and attenuated by the ongoing
scar formation around the glass fiber catheter, the backscat-
tered signal from the flexible electrode dwindled in the following
weeks (Figures 6B,C). Although the incident light attenuated pre-
dominantly in the tissue around the fiber presumably the scar
sheath, the flexible electrode was still visible in the OCT scan
demonstrating as a noticeable peak in the A-scan plot.
Although the signal of the flexible electrode was expected to
diminish due to the strong light scattering in the compact glial
sheath around the rigid fiber catheter, we observed in one case
that the signal of the flexible electrode reappeared at 6 weeks
p.i. (Figure 7). This very flexible probe was not visible after the
first week, presumably as a result of the incorrect alignment of
the flexible electrode and the fiber catheter upon implantation
(Figure 7A). At week 2 p.i. in addition to the two-layer structure
formation at the depth position of around 0.60mm in the OCT
image, a small peak was observed in the A-scan plot at the depth
position of 2.70mm (Figure 7B). At week 6 p.i. a pronounced
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signal at the depth position of 2.70mm was detected and vis-
ible both in the OCT image and the A-scan plot (Figure 7C).
We assume, that the high intensity signal that reappeared at the
image depth of 2.70mm at 6 weeks p.i. is originating from the
FIGURE 5 | Attenuation factors of the brain tissue around the fiber
catheter at week 1, 2, 3, 6, and 12.
flexible electrode. Since this polyimide-based electrode features
much lower elastic modulus compared to the conventional metal
microelectrode with similar dimensions, the flexible electrode is
supposedly able to float with the brain tissue (Jensen et al., 2007).
Therefore, during the 6 weeks the flexible electrode’s position in
the brain might alter and move back to the detection area of
the OCT fiber catheter eliciting the high intensity peak in OCT
signal.
3.3. IMMUNOREACTIVITY OF GFAP POSITIVE CELLS AND IBA-1
POSITIVE CELLS AROUND THE INSERTION TRAJECTORY
The reactivity of GFAP-positive cells are widely used to char-
acterize astrocytes star-shaped cell body (Schiffer et al., 1993;
Faulkner et al., 2004; Sofroniew, 2005). At week 1, GFAP-positive
cells are loosely distributed in an area up to 500µm from the
insertion cavity. A thin layer of the aligned GFAP-positive cells
was observed surrounding the insertion channel. At week 3,
GFAP-positive cells proliferated and spread to further areas up
to 700µm from the insertion edge with enhanced fluorescence
intensity. At week 6, the fluorescence of GFAP-positive cells in
the far area appeared reduced. Instead, a layer GFAP-positive cells
FIGURE 6 | OCT images reveal that the signal of flexible microelectrode
underneath the fiber catheter declined. (A) At 1 week, the flexible
electrode can be seen distinctly in the OCT image with a approximately 12 dB
peak height in the A-scan plot. (B) In contrast to the enhanced OCT signal of
the brain tissue, the signal of the flexible electrode severely declined. (C)
Interestingly, at 3 weeks p.i. the OCT image illustrates 2 distinguishable
tissue layers. The backscattering intensity of the flexible electrode remains
noticeable.
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FIGURE 7 | (A) At 1 week, the flexible electrode can not be seen in the OCT
image probably because of a misalignment between the flexible electrode
and the fiber catheter. (B) At 2 weeks, a small but noticeable peak appears in
the A-scan plot at the depth position of 2.70mm. (C) At 6 weeks, a
pronounced signal is revealed both in the OCT image and in the A-scan plot,
presumably, from the flexible electrode.
with high fluorescence intensity encapsulated the insertion site
(Figure 8).
We assessed the inflammatory process during the experiment
by analyzing the expression of the ionized calcium binding adap-
tor molecule (Iba-1), a marker for both resting and reactive
microglia and macrophages (Ito et al., 1998). At 1, 3, 6 weeks, the
Iba-1 expression was only found in the close area of the inser-
tion site not in the extended surrounding area (Figure 8). The
apparent distribution of fluorescence intensity and the number of
the Iba-1 positive cells didn’t demonstrate any significant changes
over time.
4. DISCUSSION
The goal of this study is to introduce a new method to monitor
and assess the scarring process around a chronically implanted
glass fiber catheter and a synchronously implanted flexible
polyimide-based microelectrode by using an OCT imaging sys-
tem (catheter type,125µm). OCT signals were acquired weekly
for 12 weeks after implantation even though no technical obsta-
cles prohibit continuous monitoring. The results corroborate that
SDOCT with an in situ implanted fiber catheter is capable of
visualizing themodification in optical properties of the surround-
ing tissue over time. During the first 3 weeks after implantation,
the intensity of the backscattered light, hence the OCT signal of
the surrounding tissue increases monotonically. The intensity lev-
els off at 6 weeks after implantation. The increased backscattering
intensity from the surrounding tissue is most likely caused by the
increased accumulation of astrocytes around the glass fiber itself,
which is referred in literature as glial encapsulation (Leach et al.,
2010). The analyzed tissue optical property “attenuation factor”
demonstrates that a compact dense tissue sheath has been devel-
oping during the 6 weeks after implantation. Since we’ve obtained
the attenuation factor of control brain tissue from a previous
study, we are able to compare the current result to naive control
tissue (Figure 9). Besides, it is promising that within the proposed
novel monitoring modality (1) the 10µm thick flexible probe is
still visible up to 2.7mm away from the fiber tip, (2) alteration
in tissue anatomical structure is noticeable in OCT A-scans, such
as the two-layered structure that developed from week 3 on in
(Figure 6).
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FIGURE 8 | GFAP and Iba-1 reactivity to the chronically implanted fiber
catheter and flexible electrode assembly at week 1, 3, and 6, respectively.
At week 1 and 3 the GFAP positive cells spread to larger area around the
insertion trajectory (1A,B, 2A,B), while at week 6 the GFAP positive cells
become less pronounced in the extended surrounding area, instead they
construct a compact layer next to the electrode and fiber (1C, 2C). Iba-1
positive cells are much smaller numbers than the GFAP positive cells at all
time points (3A–C, 4A–C). No obvious proliferation of the Iba-1 positive cells
are observed over time. Row 5 and 6 are the superimposed pictures of GFAP
(green), Iba-1 (red) and DAPI (blue) staining. Scale bar = 100µm.
Since the OCT fiber cannula itself is recognized as a foreign
body by the brain tissue, the incident light is scattered and atten-
uated already at the compact astrocyte sheath around the fiber
tip, resulting in a deteriorated detection of the flexible probe, but
at the same time providing positive control of immune response.
This shortcoming could be overcome by using a probe assem-
bly which consists of a waveguide (for OCT acquisition) that is
integrated to a flexible polyimide probe (for electrophysiology
acquisition) to gain “inside-out” views of the developing gliosis
while maintaining the probe’s flexibility.
Still, it must be noted, that the flexible probe remained visible
even at distances greater than 1mm without revealing a change
in tissue optical properties. It is a matter for ongoing investi-
gations, whether the flexible probe was indeed not covered by
a detectable glial sheath as independent immunocytochemistry
results suggest (unpublished data) or whether an existing sheath
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FIGURE 9 | Averaged attenuation factors of the brain tissue around the
fiber catheter at week 1, 2, 3, 6, and 12 are marked with black •,
attenuation factor obtained from acute experiment is marked with
blue •. Attenuation factors of other brain tissue types obtained also in
acute experiments (Xie et al., 2013) are marked with  and  respectively.
No error bars are shown, due to the littel number of animals used.
did not sufficiently backscatter for detection. In any ways, to the
best of our knowledge, the presented method appears to be the
first optical attempt to monitor brain’s immune response on deep
implants without prior markers in vivo.
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